172 Results

People

  1. Motzer
    Motzer
  2. Abrey
    Abrey
  3. De Angelis
    De Angelis
  4. Riely
    Riely
  5. Abou-Alfa
    Abou-Alfa
  6. Kelly
    Kelly
  7. Scher
    Scher
  8. Drilon
    Drilon
  9. Feldman
    Feldman
  10. Ginsberg
    Ginsberg

Groups

  1. Department of Medicine (125)
  2. Solid Tumor Oncology Division (83)
  3. Hematologic Malignancies, Division of (43)
  4. Center for Hematologic Malignancies (34)
  5. Genitourinary Oncology Service (31)
  6. Epidemiology and Biostatistics (28)
  7. Biostatistics Service (27)
  8. Thoracic Oncology (19)
  9. Division of Subspecialty Medicine (18)
  10. GSK Faculty (18)
  1. "hypophosphatemia"
Formats
  1. Journal Article (160)
  2. Review (7)
  3. Research Letter (2)
  4. Book Section (1)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (125)
  2. Solid Tumor Oncology Division (83)
  3. Hematologic Malignancies, Division of (43)
  4. Center for Hematologic Malignancies (34)
  5. Genitourinary Oncology Service (31)
  6. Epidemiology and Biostatistics (28)

More Groups

People
  1. Robert Motzer (18)
  2. Lauren Abrey (9)
  3. Lisa De Angelis (8)
  4. Gregory Riely (7)
  5. Ghassan Abou-Alfa (6)
  6. Howard Scher (6)

More People

Years
  1. 2025 (8)
  2. 2024 (13)
  3. 2023 (13)
  4. 2022 (7)
  5. 2021 (4)
  6. 2020 (21)

More Years

Publications
  1. Lancet Oncology (16)
  2. Cancer (11)
  3. Clinical Cancer Research (11)
  4. Journal of Clinical Oncology (10)
  5. New England Journal of Medicine (10)
  6. Neuro-Oncology (6)

More Publications

Publishers
  1. Elsevier Science, Inc. (25)
  2. Elsevier Inc. (19)
  3. American Association for Cancer Research (12)
  4. Wiley Blackwell (12)
  5. Oxford University Press (11)
  6. Springer (11)

More Publishers

Results (172)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ceritinib in ALK-rearranged non-small-cell lung cancer
    Journal Article

    Shaw, A. T.; Kim, D. W.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; more...
    New England Journal of Medicine (2014)

    Fulltext@MSK | Save
  • A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
    Journal Article

    Rathkopf, D. E.; Picus, J.; Hussain, A.; Ellard, S.; Chi, K. N.; Nydam, T.; Allen-Freda, E.; Mishra, K. K.; Porro, M. G.; Scher, H. I.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Pazopanib versus sunitinib in metastatic renal-cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Cella, D.; Reeves, J.; Hawkins, R.; Guo, J.; Nathan, P.; Staehler, M.; Souza, P.; Merchan, J. R.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save
  • Long-term response to sunitinib therapy for metastatic renal cell carcinoma
    Journal Article

    Molina, A. M.; Jia, X.; Feldman, D. R.; Hsieh, J. J.; Ginsberg, M. S.; Velasco, S.; Patil, S.; Motzer, R. J.
    Clinical Genitourinary Cancer (2013)

    Fulltext@MSK | Save
  • A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
    Journal Article

    Lee, J. K.; Capanu, M.; O'Reilly, E. M.; Ma, J.; Chou, J. F.; Shia, J.; Katz, S. S.; Gansukh, B.; Reidy-Lagunes, D.; Segal, N. H.; more...
    British Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Phase II study of everolimus in metastatic urothelial cancer
    Journal Article

    Milowsky, M. I.; Iyer, G.; Regazzi, A. M.; Al-Ahmadie, H.; Gerst, S. R.; Ostrovnaya, I.; Gellert, L. L.; Kaplan, R.; Garcia-Grossman, I. R.; Pendse, D.; more...
    BJU International (2013)

    Fulltext@MSK | Save
  • The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance)
    Journal Article

    Smith, S. M.; Schoder, H.; Johnson, J. L.; Jung, S. H.; Bartlett, N. L.; Cheson, B. D.
    Leukemia and Lymphoma (2013)

    Fulltext@MSK | Save
  • A pilot study of anti-CTLA4 antibody ipilimumab in patients with synovial sarcoma
    Journal Article

    Maki, R. G.; Jungbluth, A. A.; Gnjatic, S.; Schwartz, G. K.; D'Adamo, D. R.; Keohan, M. L.; Wagner, M. J.; Scheu, K.; Chiu, R.; Ritter, E.; more...
    Sarcoma (2013)

    Fulltext@MSK | Save
  • Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: Updated results from a phase 1 study
    Journal Article

    Camidge, D. R.; Bang, Y. J.; Kwak, E. L.; Iafrate, A. J.; Varella-Garcia, M.; Fox, S. B.; Riely, G. J.; Solomon, B.; Ou, S. H. I.; Kim, D. W.; more...
    Lancet Oncology (2012)

    Fulltext@MSK | Save
  • Chronic myelogenous leukemia
    Journal Article

    O'Brien, S.; Abboud, C. N.; Akhtari, M.; Altman, J.; Berman, E.; DeAngelo, D. J.; Devine, S.; Fathi, A. T.; Gotlib, J.; Jagasia, M.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save